| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Aug 24 | JAZZ Jazz Pharmaceuticals | Ordinary Shares | Grant | Acquire A | No | No | 0 | 3,731 | 0.00 | 5,231 |
| 11 Jun 24 | YMAB Y-mAbs Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 3,495 | 0.00 | 5,825 |
| 11 Jun 24 | YMAB Y-mAbs Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 12.01 | 14,545 | 174.69 k | 14,545 |
| 31 Aug 23 | PRDS Pardes Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.21 | 37,500 | 195.38 k | 0 |
| 31 Aug 23 | PRDS Pardes Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 9.8 | 75,000 | 735.00 k | 0 |
| 31 Aug 23 | PRDS Pardes Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.94 | 70,390 | 347.73 k | 0 |
| 31 Aug 23 | PRDS Pardes Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.87 | 37,500 | 70.13 k | 0 |
